Prediction of a potentially effective dose in humans for BAY 60-5521, a potent inhibitor of cholesteryl ester transfer protein (CETP) by allometric species scaling and combined pharmacodynamic and physiologically-based pharmacokinetic modelling
Open Access
- 18 July 2011
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 73 (2), 219-231
- https://doi.org/10.1111/j.1365-2125.2011.04064.x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Single dose pharmacokinetics, pharmacodynamics, tolerability and safety of BAY 60-5521, a potent inhibitor of cholesteryl ester transfer proteinBritish Journal of Clinical Pharmacology, 2012
- Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trialEuropean Heart Journal, 2010
- Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorptionJournal of Pharmacy and Pharmacology, 2009
- Defining the Role of Macrophages in Local Moxifloxacin Tissue Concentrations using Biopsy Data and Whole-Body Physiologically Based Pharmacokinetic ModellingClinical Pharmacokinetics, 2009
- Physiology-Based Simulations of a Pathological ConditionClinical Pharmacokinetics, 2008
- Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) modelsTheoretical Biology and Medical Modelling, 2007
- Development and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for ChildrenClinical Pharmacokinetics, 2006
- Prediction of Hepatic Metabolic Clearance Based on Interspecies Allometric Scaling Techniques and In Vitro-In Vivo CorrelationsClinical Pharmacokinetics, 1999
- Remodelling of lipoproteins in transgenic mice expressing human cholesteryl ester transfer proteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1982